INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 159 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $236,000 | -10.6% | 5,700 | +81.0% | 0.02% | -15.4% |
| Q2 2018 | $264,000 | -30.7% | 3,150 | 0.0% | 0.03% | -48.0% |
| Q2 2017 | $381,000 | +7.0% | 3,150 | 0.0% | 0.05% | +8.7% |
| Q1 2017 | $356,000 | +4.1% | 3,150 | 0.0% | 0.05% | +7.0% |
| Q4 2016 | $342,000 | -52.2% | 3,150 | -27.6% | 0.04% | -55.2% |
| Q3 2016 | $716,000 | +15.3% | 4,350 | 0.0% | 0.10% | +21.5% |
| Q2 2016 | $621,000 | +12.5% | 4,350 | +1.2% | 0.08% | +16.2% |
| Q1 2016 | $552,000 | -14.0% | 4,300 | 0.0% | 0.07% | -6.8% |
| Q4 2015 | $642,000 | – | 4,300 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |